These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20409288)

  • 1. Use of nail and oral pigmentation to determine ART eligibility among HIV-infected Ugandan adults.
    Namakoola I; Wakeham K; Parkes-Ratanshi R; Levin J; Mugagga T; Seymour C; Kissa J; Kamali A; Lalloo DG
    Trop Med Int Health; 2010 Feb; 15(2):259-62. PubMed ID: 20409288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grey nails predict low CD4 cell count among untreated patients with HIV infection in Malawi.
    Scarborough M; Gordon SB; French N; Phiri C; Musaya J; Zijlstra EE
    AIDS; 2006 Jun; 20(10):1415-7. PubMed ID: 16791016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of mucocutaneous manifestations of HIV-infected patients in an ART center with CD4 counts.
    Lahoti S; Rao K; Umadevi HS; Mishra L
    Indian J Dent Res; 2017; 28(5):549-554. PubMed ID: 29072219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.
    Johnson OO; Benjamin DK; Benjamin DK; Schimana W; Tillekeratne LG; Crump JA; Landman KZ; Kinabo GD; Mmbaga B; Msuya LJ; Shao JF; Swai ME; Cunningham CK
    Pediatr Infect Dis J; 2009 Jun; 28(6):493-7. PubMed ID: 19436238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laugier-Hunziker syndrome: a rare cause of mucocutaneous pigmentation.
    Sabesan T; Ramchandani PL; Peters WJ
    Br J Oral Maxillofac Surg; 2006 Aug; 44(4):320-1. PubMed ID: 15964106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucosal lesions and immune status in HIV-infected Indian children.
    Subramaniam P; Kumar K
    J Oral Pathol Med; 2015 Apr; 44(4):296-9. PubMed ID: 25212254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a clinical scoring system for assessment of immunosuppression in patients with tuberculosis and HIV infection without access to CD4 cell testing--results from a cross-sectional study in Ethiopia.
    Skogmar S; Balcha TT; Jemal ZH; Björk J; Deressa W; Schön T; Björkman P
    Glob Health Action; 2014; 7():23105. PubMed ID: 24560255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic lenticular mucocutaneous pigmentation (Laugier-Hunziker syndrome): a report of a case.
    Siponen M; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Sep; 96(3):288-92. PubMed ID: 12973285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M
    HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Opportunistic Infections among HIV-Positive Adults on Highly Active Antiretroviral Therapy in a Teaching Hospital, India: Prospective Study.
    Shenoy N; Ramapuram JT; Shenoy A; Ahmed J; Srikant N
    J Int Assoc Provid AIDS Care; 2017; 16(3):309-311. PubMed ID: 28050923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.
    Diomandé FV; Bissagnéné E; Nkengasong JN; Maurice C; Monga B; Laga M; Nolan ML
    AIDS; 2003 Jul; 17 Suppl 3():S87-93. PubMed ID: 14565614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperpigmented spots on the lips, oral mucosa, fingers and nails].
    Paricio Rubio JF; Revenga Arranz F; Ramírez Gasca T
    Rev Clin Esp; 1998 Nov; 198(11):769-70. PubMed ID: 9883053
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
    Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
    J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.
    Jambo KC; Banda DH; Afran L; Kankwatira AM; Malamba RD; Allain TJ; Gordon SB; Heyderman RS; Russell DG; Mwandumba HC
    Am J Respir Crit Care Med; 2014 Oct; 190(8):938-47. PubMed ID: 25225948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients.
    Daneau G; Buyze J; Wade D; Diaw PA; Dieye TN; Sopheak T; Florence E; Lynen L; Kestens L
    Cytometry B Clin Cytom; 2017 Nov; 92(6):476-484. PubMed ID: 26917223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.